These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 2422193

  • 1. Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase.
    Ljungman P, Wahren B, Sundqvist VA.
    J Virol Methods; 1985 Dec; 12(3-4):199-208. PubMed ID: 2422193
    [Abstract] [Full Text] [Related]

  • 2. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
    Schmidt NJ, Gallo D.
    J Med Virol; 1984 Dec; 13(1):1-12. PubMed ID: 6319583
    [Abstract] [Full Text] [Related]

  • 3. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study.
    Aarnisalo J, Ilonen J, Vainionpää R, Volanen I, Kaitosaari T, Simell O.
    Scand J Infect Dis; 2003 Dec; 35(10):750-3. PubMed ID: 14606615
    [Abstract] [Full Text] [Related]

  • 4. Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies.
    Doerr HW, Rentschler M, Scheifler G.
    Infection; 1987 Dec; 15(2):93-8. PubMed ID: 3036714
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.
    Sørensen OS, Haahr S, Møller-Larsen A, Wildenhoff K.
    Infect Immun; 1980 Aug; 29(2):369-75. PubMed ID: 6163709
    [Abstract] [Full Text] [Related]

  • 7. [Prevention and therapy of herpesvirus infections].
    Abb J.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [Abstract] [Full Text] [Related]

  • 8. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients.
    Cheng FW, Chan PK, Lee V, Leung WK, Shing MK, Li CK, Leung TF.
    Pediatr Transplant; 2010 Sep 01; 14(6):761-9. PubMed ID: 20534025
    [Abstract] [Full Text] [Related]

  • 9. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C.
    G Batteriol Virol Immunol; 1991 Sep 01; 84(1-12):41-52. PubMed ID: 1668971
    [Abstract] [Full Text] [Related]

  • 10. Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.
    Källander CF, Torfason EG, Olding-Stenkvist E, Sundqvist VA, Diderholm H, Gronowitz JS.
    J Med Virol; 1989 May 01; 28(1):30-7. PubMed ID: 2542443
    [Abstract] [Full Text] [Related]

  • 11. Immunological cross-reactivities among three herpesviruses.
    Ndumbe PM, Levinsky RJ.
    J Immunol Methods; 1985 Nov 07; 83(2):337-42. PubMed ID: 2997331
    [Abstract] [Full Text] [Related]

  • 12. Differentiation of members of the human herpesviridae family by radioimmunoassay.
    Smith KO, Kennell W.
    Infect Immun; 1981 Aug 07; 33(2):491-7. PubMed ID: 6268545
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of sensitive and enzyme-linked immunoassays for herpesvirus antigens and some applications.
    Sundqvist VA, Wahren B.
    Dev Biol Stand; 1982 Aug 07; 52():245-53. PubMed ID: 6299833
    [Abstract] [Full Text] [Related]

  • 15. Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.
    Boström L, Ringdén O, Forsgren M.
    Scand J Immunol; 1991 Jul 07; 34(1):45-52. PubMed ID: 1648786
    [Abstract] [Full Text] [Related]

  • 16. The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation.
    de Gast GC, Gratama JW, Verdonck LF, van Heugten JG, Zwaan FE, Phillips DI, Mudde GC.
    Transplantation; 1989 Jul 07; 48(1):111-5. PubMed ID: 2546299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
    Haahr S, Møller-Larsen A, Pedersen E.
    Clin Exp Immunol; 1983 Feb 07; 51(2):197-206. PubMed ID: 6188564
    [Abstract] [Full Text] [Related]

  • 19. Fine specificities of antibodies in sera and cerebrospinal fluid in herpes virus infections of the central nervous system as detected by the antigen variable immunoblot technique.
    Neumann B, Ritter K, Felgenhauer K.
    J Neuroimmunol; 1990 Jul 07; 28(2):111-8. PubMed ID: 2163408
    [Abstract] [Full Text] [Related]

  • 20. IgG subclass distribution of antiviral antibodies in common variable immunodeficiency: effect of substitution therapy.
    Linde A, Hammarström L, Smith CI.
    Clin Immunol Immunopathol; 1988 Dec 07; 49(3):341-8. PubMed ID: 2847890
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.